KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lam Research (LRCX) Shares Outstanding (Weighted Average) (2016 - 2026)

Lam Research has reported Shares Outstanding (Weighted Average) over the past 18 years, most recently at $1.3 billion for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 2.61% year-over-year to $1.3 billion; the TTM value through Mar 2026 reached $1.3 billion, down 2.61%, while the annual FY2025 figure was $1.3 billion, 2.13% down from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 was $1.3 billion at Lam Research, roughly flat from $1.3 billion in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $1.4 billion in Q2 2023 and troughed at $135.9 million in Q1 2023.
  • A 5-year average of $956.8 million and a median of $1.3 billion in 2025 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): decreased 3.42% in 2022 and later surged 868.54% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $136.5 million in 2022, then skyrocketed by 864.64% to $1.3 billion in 2023, then dropped by 1.76% to $1.3 billion in 2024, then dropped by 2.59% to $1.3 billion in 2025, then decreased by 0.26% to $1.3 billion in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for LRCX at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.